Clinical Trial Update: A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing indapamide SR 1.5 mg to hydrochlorothiazide 25 mg, each in combination with an ACE inhibitor, in patients with mild-to-moderate hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Hydrochlorothiazide 25 mg (hydrochlorothiazide)
• Indapamide SR 1.5 mg (indapamide)

Snippet

Sponsor: LaborMed Pharma S.A. | Conditions: Hypertension, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED